858O Results of KEYNOTE-122: A phase III study of pembrolizumab (pembro) monotherapy vs chemotherapy (chemo) for platinum-pretreated, recurrent or metastatic (R/M) nasopharyngeal carcinoma (NPC)
Anthony T.�C. Chan, Victor Lee, R-L. Hong, M-J. Ahn, Wan Qin Chong, S-B. Kim, Gwo Fuang Ho, Priscilla B. Caguioa, Nuttapong Ngamphaiboon, Gwo Fuang Ho, M.A.S. Abdul Aziz, Quan Sing Ng, C-J. Yen, Nopadol Soparattanapaisarn, K.C. Ngan, S.K. Kho, Ramona F. Swaby, Sanatan Saraf, Joy Yang Ge, L.L. Siu
Topics & Concepts
MedicinePembrolizumabChemotherapyNasopharyngeal carcinomaOncologyInternal medicinePhases of clinical researchRadiation therapyCancerImmunotherapyHead and Neck Cancer StudiesPeptidase Inhibition and AnalysisCancer Immunotherapy and Biomarkers